263 results on '"Galac, Sara"'
Search Results
2. Concurrent endocrine neoplasia
3. Metabolomic profiling of pheochromocytomas in dogs: Catecholamine phenotype and tricarboxylic acid cycle metabolites.
4. Editorial: Advances in veterinary endocrine oncology
5. Editorial: Advances in veterinary endocrine oncology
6. Canine phaeochromocytoma: a guide to diagnosis and treatment
7. Whole transcriptome analysis of canine pheochromocytoma and paraganglioma
8. Melanocortin 2 receptor antagonists in canine pituitary-dependent hypercortisolism: in vitro studies
9. Challenges of transsphenoidal pituitary surgery in severe brachycephalic dogs
10. Crooke's cell pituitary adenoma in a 7‐month‐old dog with Cushing's syndrome
11. Plasma and urinary metanephrine and normetanephrine concentrations using liquid chromatography with tandem mass spectrometry in healthy cats and in a cat with pheochromocytoma
12. Reference intervals for plasma, urinary, and salivary concentrations of free metanephrines in dogs: Relevance to the diagnosis of pheochromocytoma
13. Plasma and urinary metanephrine and normetanephrine concentrations using liquid chromatography with tandem mass spectrometry in healthy cats and in a cat with pheochromocytoma
14. Challenges of transsphenoidal pituitary surgery in severe brachycephalic dogs
15. Transcriptome sequencing reveals two subtypes of cortisol-secreting adrenocortical tumours in dogs and identifies CYP26B1 as a potential new therapeutic target
16. Whole transcriptome analysis of canine pheochromocytoma and paraganglioma
17. Crooke's cell pituitary adenoma in a 7-month-old dog with Cushing's syndrome
18. Laparoscopic vs. open adrenalectomy: perioperative data and survival analysis in 70 dogs with an adrenal tumor
19. Transcriptome sequencing reveals two subtypes of cortisol-secreting adrenocortical tumours in dogs and identifies CYP26B1 as a potential new therapeutic target
20. Transcriptome sequencing reveals two subtypes of cortisol‐secreting adrenocortical tumours in dogs and identifies CYP26B1 as a potential new therapeutic target
21. Reference intervals for plasma, urinary, and salivary concentrations of free metanephrines in dogs: Relevance to the diagnosis of pheochromocytoma
22. Comparison of methods to monitor dogs with hypercortisolism treated with trilostane
23. Ultrasonographic Detected Adrenomegaly in Clinically Ill Cats: A Retrospective Study
24. Hypocortisolism in a dog caused by bilateral pheochromocytoma
25. Ultrasonographic Detected Adrenomegaly in Clinically Ill Cats: A Retrospective Study
26. CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles
27. Recent Advances in the Diagnosis of Cushing's Syndrome in Dogs
28. Reference intervals for plasma, urinary, and salivary concentrations of free metanephrines in dogs: Relevance to the diagnosis of pheochromocytoma
29. Circulating MicroRNAs as Non-invasive Biomarkers for Canine Cushing's Syndrome
30. Primary hyperaldosteronism: Expanding the diagnostic net
31. CDC6 : A novel canine tumour biomarker detected in circulating extracellular vesicles
32. Long-term follow-up of renal function assessing serum cystatin C in dogs with diabetes mellitus or hyperadrenocorticism
33. Effects of trilostane on the pituitary-adrenocortical and renin–aldosterone axis in dogs with pituitary-dependent hypercortisolism
34. Circulating microRNAs as noninvasive biomarkers for canine Cushing’s syndrome
35. Molecular markers of prognosis in canine cortisol‐secreting adrenocortical tumours
36. Pituitary tumour types in dogs and cats
37. Evaluation of hypophysectomy for treatment of hypersomatotropism in 25 cats
38. Canine Pituitary Organoids as 3D In Vitro Model for Cushing Disease
39. Melanocortin 2 Receptor Antagonists in Canine Cushing’s Disease: In Vitro Studies
40. Feline plasma adrenocorticotropic hormone: validation of a chemiluminescent assay and concentrations in cats with hypercortisolism, primary hypoadrenocorticism and other diseases
41. Circulating MicroRNAs as Non-invasive Biomarkers for Canine Cushing's Syndrome
42. Comparison of methods to monitor dogs with hypercortisolism treated with trilostane
43. Canine Pituitary Organoids as 3D In Vitro Model for Cushing Disease
44. Melanocortin 2 Receptor Antagonists in Canine Cushing’s Disease: In Vitro Studies
45. Evaluation of hypophysectomy for treatment of hypersomatotropism in 25 cats
46. Pituitary tumour types in dogs and cats
47. Planar and single-photon emission computed tomography imaging in dogs with thyroid tumors: 68 cases
48. CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles.
49. Planar and single-photon emission computed tomography imaging in dogs with thyroid tumors: 68 cases
50. Feline plasma adrenocorticotropic hormone: validation of a chemiluminescent assay and concentrations in cats with hypercortisolism, primary hypoadrenocorticism and other diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.